Indaptus Therapeutics News

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 22:40

Indaptus Therapeutics | 8-K: Current report

Oct 22 20:08

Indaptus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Sep 13 04:49

Indaptus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 12 20:20

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 20:05

Indaptus Therapeutics | 8-K: Current report

Aug 8 20:04

Indaptus Therapeutics | 8-K: Current report

Jun 8 04:34

Indaptus Therapeutics | 8-K: Current report

May 22 20:04

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 8 20:08

Indaptus Therapeutics | DEFA14A: Others

Apr 26 21:08

Indaptus Therapeutics | DEF 14A: Definitive information statements

Apr 26 21:03

Indaptus Therapeutics | 8-K: Current report

Mar 25 20:33

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Mar 13 20:03

Indaptus Therapeutics | 8-K: Current report

Mar 5 00:05

Indaptus Therapeutics | 8-K: Current report

Jan 23 13:00

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 7, 2023 05:05

Indaptus Therapeutics | 8-K: Current report

Nov 6, 2023 21:13

Indaptus Therapeutics | 8-K: Current report

Oct 31, 2023 21:12

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 14, 2023 20:10

Indaptus Therapeutics | 8-K: Current report

Aug 10, 2023 20:45